Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Provision of Patient Services

Sponsored by

Finalist

"touch" Patient Support Programme

LEO Pharma in association with Atlantis Healthcare


Summary of work

In the UK, approximately 1.2 million people have psoriasis, a chronic condition, which can often cause feelings of low-esteem, depression and social isolation. Furthermore, 40 per cent of patients prescribed a topical treatment do not use it as prescribed. 

In conjunction with health psychologists, dermatologists and patients, LEO Pharma has therefore developed “touch” – an evidence-based support programme designed to improve adherence and health outcomes for people living with psoriasis. 

Available to everyone with psoriasis aged over 18 in the UK (and their loved ones); users can access the touch website and helpline, and also receive belief-based interventional content through a variety of media channels. 

touch aims to improve members’ beliefs about their treatment and condition, by offering tailored support and coping strategies to encourage better disease self-management. An interim measurement sample shows the programme has reduced by over 85 per cent (exceeding objective of 70 per cent) the number of interviewees holding unhelpful beliefs, identified in the research as key predictors of non-adherence.

Launched in April 2011, touch currently supports 7,056 members.

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics